Trial Profile
Clinical Trials Insight: 700033503
Status:
Planning
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 May 2008
Price :
$35
*
At a glance
- Drugs VK 2809 (Primary) ; HMG-CoA reductase inhibitors
- Indications Hyperlipidaemia
- Focus Adverse reactions
- Sponsors Metabasis Therapeutics
- 13 May 2008 New trial record.